0001077183-21-000084.txt : 20210303 0001077183-21-000084.hdr.sgml : 20210303 20210303201823 ACCESSION NUMBER: 0001077183-21-000084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALLIET JENNIFER CENTRAL INDEX KEY: 0001640500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 21711962 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 wf-form4_161482068265167.xml FORM 4 X0306 4 2021-03-01 0 0001077183 NEOGENOMICS INC NEO 0001640500 BALLIET JENNIFER 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 VP and Chief Culture Officer Common Stock 2021-03-01 4 F 0 212 0 D 24768 D Common Stock 2021-03-02 4 F 0 173 0 D 24595 D Common Stock 2021-03-02 4 A 0 1862 0 A 26457 D Stock Option (Right to Buy) 7.52 2022-04-28 Common Stock 7000.0 7000 D Stock Option (Right to Buy) 8.03 2023-02-26 Common Stock 33334.0 33334 D Stock Option (Right to Buy) 19.6 2024-03-01 Common Stock 17496.0 17496 D Stock Option (Right to Buy) 28.33 2027-03-02 Common Stock 15006.0 15006 D Stock Option (Right to Buy) 53.17 2021-03-02 4 A 0 10551 53.17 A 2028-03-02 Common Stock 10551.0 10551 D Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock. Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock. On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date. On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date. On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date. On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date. /s/Jennifer Balliet 2021-03-03